Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.270
-0.060 (-4.51%)
At close: Apr 1, 2025, 4:00 PM
1.282
+0.012 (0.93%)
After-hours: Apr 1, 2025, 7:56 PM EDT

Quince Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
56824523377819
Upgrade
Market Cap Growth
82.80%82.80%95.46%-93.89%-53.99%-45.64%
Upgrade
Enterprise Value
3050-38-71264682
Upgrade
Last Close Price
1.271.871.050.6412.6227.78
Upgrade
PB Ratio
1.852.730.530.233.184.76
Upgrade
P/TBV Ratio
--11.890.243.184.76
Upgrade
Debt / Equity Ratio
0.490.490.160.010.010.00
Upgrade
Quick Ratio
5.735.737.9529.717.597.87
Upgrade
Current Ratio
6.056.058.0930.557.858.11
Upgrade
Return on Equity (ROE)
-98.63%-98.63%-33.81%-47.14%-61.85%-53.42%
Upgrade
Return on Assets (ROA)
-14.90%-14.90%-11.33%-26.40%-34.99%-31.42%
Upgrade
Return on Capital (ROIC)
-29.26%-29.26%-15.40%-28.36%-38.60%-34.22%
Upgrade
Earnings Yield
-101.69%-69.06%-69.73%-224.32%-23.86%-9.38%
Upgrade
FCF Yield
-57.55%-39.09%-40.99%-191.80%-16.74%-6.21%
Upgrade
Buyback Yield / Dilution
-16.18%-16.18%-11.17%-12.71%-1.86%-53.30%
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q